tert-butyl 4-[2-(3-{[1-(1-methyl-1H-pyrazol-4-yl)-4-oxo-1,4-dihydropyridazin-3-yl]methyl}phenyl)pyrimidin-5-yl]-3,6-dihydropyridine-1(2H)-carboxylate | 1314392-35-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: tert-butyl 4-[2-(3-{[1-(1-methyl-1H-pyrazol-4-yl)-4-oxo-1,4-dihydropyridazin-3-yl]methyl}phenyl)pyrimidin-5-yl]-3,6-dihydropyridine-1(2H)-carboxylate
• 英文别名: tert-butyl 4-[2-[3-[[1-(1-methylpyrazol-4-yl)-4-oxopyridazin-3-yl]methyl]phenyl]pyrimidin-5-yl]-3,6-dihydro-2H-pyridine-1-carboxylate
• CAS: 1314392-35-2
• 化学式: C₂₉H₃₁N₇O₃
• 分子量: 525.61
• InChiKey: SRTHDFTUFRGMDC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  39
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  106
• 氢给体数：
  0
• 氢受体数：
  8

文献信息

• [EN] TYROSINE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE TYROSINE KINASE
  申请人：MERCK SHARP & DOHME

  公开号：WO2011084402A1

  公开（公告）日：2011-07-14

  The present invention relates to pyridazin-4(1H)-one derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

  本发明涉及吡啶并嗪-4(1H)-酮衍生物，用于治疗细胞增殖性疾病，治疗与MET活性相关的疾病，并抑制受体酪氨酸激酶MET。该发明还涉及包含这些化合物的组合物，以及利用它们治疗哺乳动物癌症的方法。
• TYROSINE KINASE INHIBITORS
  申请人：Young Jonathan

  公开号：US20120264735A1

  公开（公告）日：2012-10-18

  The present invention relates to pyridazin-4(1H)-one derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

  本发明涉及吡啶并嗪-4(1H)-酮衍生物，用于治疗细胞增殖性疾病，治疗与MET活性相关的疾病，以及抑制受体酪氨酸激酶MET。本发明还涉及包含这些化合物的组合物和使用它们治疗哺乳动物癌症的方法。